A detailed history of Silvercrest Asset Management Group LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Silvercrest Asset Management Group LLC holds 5,436 shares of LLY stock, worth $4.1 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
5,436
Previous 5,087 6.86%
Holding current value
$4.1 Million
Previous $4.61 Million 4.56%
% of portfolio
0.03%
Previous 0.03%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$772.14 - $960.02 $269,476 - $335,046
349 Added 6.86%
5,436 $4.82 Million
Q2 2024

Aug 14, 2024

SELL
$724.87 - $909.04 $3.69 Million - $4.62 Million
-5,087 Reduced 50.0%
5,087 $4.61 Million
Q2 2024

Aug 14, 2024

BUY
$724.87 - $909.04 $3.68 Million - $4.62 Million
5,080 Added 99.73%
10,174 $9.21 Million
Q1 2024

May 15, 2024

SELL
$592.2 - $792.28 $159,301 - $213,123
-269 Reduced 5.02%
5,094 $3.96 Million
Q4 2023

Feb 14, 2024

BUY
$525.19 - $619.13 $159,132 - $187,596
303 Added 5.99%
5,363 $3.13 Million
Q3 2023

Nov 14, 2023

BUY
$434.7 - $599.3 $11,302 - $15,581
26 Added 0.52%
5,060 $2.72 Million
Q2 2023

Aug 14, 2023

BUY
$350.74 - $468.98 $246,570 - $329,692
703 Added 16.23%
5,034 $2.36 Million
Q1 2023

May 15, 2023

BUY
$310.63 - $364.82 $7,765 - $9,120
25 Added 0.58%
4,331 $1.49 Million
Q4 2022

Feb 14, 2023

SELL
$321.55 - $374.67 $24,116 - $28,100
-75 Reduced 1.71%
4,306 $1.58 Million
Q2 2022

Aug 15, 2022

SELL
$278.73 - $327.27 $5,574 - $6,545
-20 Reduced 0.45%
4,381 $1.42 Million
Q1 2022

May 16, 2022

SELL
$234.69 - $291.66 $67,825 - $84,289
-289 Reduced 6.16%
4,401 $1.26 Million
Q4 2021

Feb 14, 2022

BUY
$224.85 - $279.04 $1,573 - $1,953
7 Added 0.15%
4,690 $1.3 Million
Q3 2021

Nov 15, 2021

BUY
$221.6 - $272.71 $390,016 - $479,969
1,760 Added 60.21%
4,683 $1.08 Million
Q2 2021

Aug 16, 2021

SELL
$180.55 - $233.54 $269,922 - $349,142
-1,495 Reduced 33.84%
2,923 $671,000
Q1 2021

May 17, 2021

SELL
$164.32 - $212.72 $48,474 - $62,752
-295 Reduced 6.26%
4,418 $825,000
Q4 2020

Feb 16, 2021

BUY
$130.46 - $172.63 $8,349 - $11,048
64 Added 1.38%
4,713 $796,000
Q3 2020

Nov 16, 2020

BUY
$146.22 - $169.13 $7,018 - $8,118
48 Added 1.04%
4,649 $688,000
Q2 2020

Aug 14, 2020

SELL
$136.42 - $164.18 $2,728 - $3,283
-20 Reduced 0.43%
4,601 $755,000
Q1 2020

May 15, 2020

SELL
$119.05 - $147.35 $169,646 - $209,973
-1,425 Reduced 23.57%
4,621 $641,000
Q4 2019

Feb 14, 2020

BUY
$106.92 - $132.43 $148,832 - $184,342
1,392 Added 29.91%
6,046 $795,000
Q3 2019

Nov 14, 2019

BUY
$106.79 - $116.16 $1,174 - $1,277
11 Added 0.24%
4,654 $520,000
Q1 2019

May 15, 2019

SELL
$111.31 - $131.02 $1,669 - $1,965
-15 Reduced 0.32%
4,643 $602,000
Q4 2018

Feb 14, 2019

SELL
$105.9 - $118.64 $263,161 - $294,820
-2,485 Reduced 34.79%
4,658 $539,000
Q3 2018

Nov 14, 2018

BUY
$85.86 - $107.31 $9,616 - $12,018
112 Added 1.59%
7,143 $767,000
Q1 2018

May 15, 2018

SELL
$74.21 - $87.6 $148,420 - $175,200
-2,000 Reduced 22.15%
7,031 $544,000
Q4 2017

Feb 14, 2018

BUY
$81.94 - $87.89 $158,471 - $169,979
1,934 Added 27.25%
9,031 $763,000
Q3 2017

Nov 14, 2017

BUY
$77.07 - $85.54 $546,965 - $607,077
7,097
7,097 $607,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $717B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Silvercrest Asset Management Group LLC Portfolio

Follow Silvercrest Asset Management Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silvercrest Asset Management Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silvercrest Asset Management Group LLC with notifications on news.